GlassScriptPhysician profile
Matthew D Copple
NPI 1033315742
$12,444.52
in general payments reported to CMS, 2019-2025
26 companies · $3,735 in 2025
The $3,735 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,100 · 2020: $764 · 2021: $754 · 2022: $390 · 2023: $3,025 · 2024: $2,676 · 2025: $3,735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,680 · Food and Beverage: $3,184 · Education: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,679.81 |
| Food and Beverage | $3,183.85 |
| Education | $572.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,743.04 | 2022-2025 | Avenir, Oxford, Persona |
| Depuy Synthes Sales INC. | $2,028.10 | 2023-2025 | Inhance, Attune, Velys |
| Arthrex, INC. | $1,766.24 | 2024-2025 | |
| Foundation Medical, LLC | $1,465.31 | 2023-2025 | |
| Amgen INC. | $648.63 | 2019-2022 | |
| Horizon Therapeutics Plc | $554.79 | 2019-2022 | |
| Stryker Corporation | $471.11 | 2019-2022 | |
| Radius Health, INC. | $399.23 | 2019-2022 | |
| Pacira Therapeutics, INC. | $351.19 | 2019-2021 | |
| Medical Device Business Services, INC. | $240.24 | 2023-2025 | Velys |
| Smith+Nephew, INC. | $216.89 | 2023 | Smart Tsf |
| Arbor Pharmaceuticals, INC. | $174.10 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $68.92 | 2020-2021 | |
| Fidia Pharma USA INC. | $62.87 | 2021 | |
| Forte Bio-Pharma LLC | $53.78 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $37.48 | 2019 | |
| Ferring Pharmaceuticals INC. | $26.43 | 2019-2020 | |
| Vericel Corporation | $21.80 | 2021 | |
| Bioventus LLC | $19.37 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.28 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.10 | 2022 | |
| Argon Medical Devices, INC. | $15.53 | 2022 | |
| Pfizer INC. | $14.79 | 2019 | |
| Avanos Medical | $14.44 | 2022 | |
| Shionogi INC | $12.04 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $5.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Copple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.